Ethnic differences in cancer risk resulting from genetic variation

Area of Science:

• Genetics
• Oncology
• Epidemiology

Background:

• Ethnic disparities in cancer incidence and mortality are influenced by genetic and environmental factors.
• Founder mutations, particularly in BRCA1 and BRCA2, play a role in these ethnic variations.
• Germline mutations in cancer susceptibility genes are present across all racial and ethnic groups.

Purpose of the Study:

• To review the role of founder mutations in cancer susceptibility genes, emphasizing BRCA1 and BRCA2.
• To explore how studying specific ethnic groups can inform broader cancer risk understanding.
• To analyze the contribution of specific mutations to cancer risk in different populations.

Main Methods:

• Review of existing literature on founder mutations in cancer predisposition genes.
• Emphasis on well-characterized mutations in specific ethnic groups, such as Ashkenazic Jews and Icelanders.
• Analysis of the prevalence and impact of BRCA1 and BRCA2 mutations.

Main Results:

• Founder mutations in cancer predisposition genes contribute to ethnic variations in cancer risk.
• Specific mutations, like BRCA2 999del5 in Iceland and three mutations in Ashkenazic Jews, have been well-characterized.
• BRCA1 and BRCA2 mutations account for a significant proportion of breast cancer, especially in families with a history of breast and ovarian cancers.

Conclusions:

• Founder mutations identified in specific ethnic groups can explain some ethnic variations in cancer risk.
• Studying mutations in well-defined populations provides insights applicable to more diverse populations.
• While individuals of all backgrounds carry mutations, they are often easier to identify and study within specific ethnic groups.